Human normal immunoglobulin

Xembify 200 mg/ml oplossing voor subcutane injectie

Oplossing voor injectieNetherlandsAuthorisedAuthorised 18 Aug 2025

In other countries

The same active substances on other registers, the same brand first.

Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
Flebogamma Dif Solution for Infusion 10%Singapore · 100mg/ml · infusion, solution · Grifols Asia Pacific Pte. LTD.Same form
Flebogamma Dif Solution for Infusion 5%Singapore · 50 mg/ml · infusion, solution · Grifols Asia Pacific Pte. LTD.Same form
Gamunex®-C Solution for Infusion 10%Singapore · 0.1g /mL · injection, solution · Grifols Asia Pacific Pte. LTD.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Human normal immunoglobulin

Xembify 200 mg/ml oplossing voor subcutane injectie

Oplossing voor injectieNetherlandsAuthorisedAuthorised 18 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

DeqsigaEuropean Union · Takeda Manufacturing Austria AG

Flebogamma DIF (previously Flebogammadif)European Union · Instituto Grifols S.A.

HizentraEuropean Union · CSL Behring GmbH

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.